Placebo
ND002
Phase 3 small_molecule active
Quick answer
Placebo for Parkinsons Disease (PD) is a Phase 3 program (small_molecule) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Parkinsons Disease (PD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active